Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-25 @ 4:26 AM
NCT ID:
NCT00003320
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed cerebral metastases post surgical resection
* No greater than 3 cerebral metastases postresection
* Gross resection at operation as documented in operation note and postoperative MRI Patients must have current surgical sites that have not been previously irradiated
* No other indication for whole brain irradiation (i.e., multiple untreated metastases not suitable for single fraction stereotactic radiotherapy, leptomeningeal disease)
* Age: 18 and over
* Karnofsky 60-100%
* Life expectancy: At least 3 months
* Prior or concurrent required steroids allowed
* Prior stereotactic radiotherapy of cerebral metastases allowed provided no prior irradiation of current surgical sites
* Prior surgery of cerebral metastases allowed
Exclusion Criteria:
* severe asthma requiring therapy
* allergy to iodine or contrast media
* pregnant
* concurrent chemotherapy
* prior whole brain irradiation or focal irradiation to current sites of disease
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00003320
Study Brief:
Protocol Section:
NCT00003320